ClearPoint Neuro (CLPT) EBITDA Yield: History & Chart

ClearPoint Neuro, Inc.(CLPT)

Medical - Devices · Solana Beach, CA

$11.39-0.13 (-1.16%)

Delayed quote: Oct 6, 2026, 10:05 AM EDT

About ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.

Solana Beach, CA

172 employees

www.clearpointneuro.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Joseph Michael Burnett

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
ClearPoint Neuro, Inc. (CLPT)	$341.46M	N/A	N/A	N/A	N/A
Artiva Biotherapeutics, Inc. (ARTV)vs ›	$340.28M	N/A	N/A	N/A	N/A
Agenus Inc. (AGEN)vs ›	$342.72M	11.22%	6.91%	6.91%	10.15%
Cabaletta Bio, Inc. (CABA)vs ›	$326.11M	N/A	N/A	N/A	N/A
Embecta Corp. (EMBC)vs ›	$354.48M	18.59%	21.70%	14.93%	15.13%
C4 Therapeutics, Inc. (CCCC)vs ›	$325.07M	N/A	N/A	N/A	N/A
Enanta Pharmaceuticals, Inc. (ENTA)vs ›	$357.37M	N/A	3.28%	4.15%	7.65%
Fennec Pharmaceuticals Inc. (FENC)vs ›	$357.44M	N/A	3.23%	3.23%	3.23%
Opus Genetics, Inc. (IRD)vs ›	$359.05M	N/A	N/A	N/A	N/A
CapsoVision, Inc. (CV)vs ›	$323.01M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

ClearPoint Neuro, Inc. (CLPT)

$341.46M

N/A

Artiva Biotherapeutics, Inc. (ARTV)vs ›

$340.28M

N/A

Agenus Inc. (AGEN)vs ›

$342.72M

11.22%

6.91%

10.15%

Cabaletta Bio, Inc. (CABA)vs ›

$326.11M

N/A

Embecta Corp. (EMBC)vs ›

$354.48M

18.59%

21.70%

14.93%

15.13%

C4 Therapeutics, Inc. (CCCC)vs ›

$325.07M

N/A

Enanta Pharmaceuticals, Inc. (ENTA)vs ›

$357.37M

N/A

3.28%

4.15%

7.65%

Fennec Pharmaceuticals Inc. (FENC)vs ›

$357.44M

N/A

3.23%

Opus Genetics, Inc. (IRD)vs ›

$359.05M

N/A

CapsoVision, Inc. (CV)vs ›

$323.01M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

CLPT EBITDA Yield Metrics

CLPT Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics